Evidence map›Paper›PMID 42462051›Full record

ArticleJournal of medical Internet research2026

Consensus Statement on Digital Health and Attention-Deficit/Hyperactivity Disorder by the European Network for ADHD (EUNETHYDIS): Modified Delphi Study.

Anna Price, Emi Furukawa, Alessio Bellato, Pascal-M Aggensteiner, Matthew Bellringer, Claire Cattel, Samuele Cortese, David Daley, Manfred Döpfner, Federica Donno and 16 more

Abstract readConsensus Statement
In one paragraph

Article in Journal of medical Internet research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Anna Price *Faculty of Health and Life Sciences, University of Exeter, Room 2.05, South Cloisters, University of Exeter St Luke's Campus Heavitree Road, Exeter, EX1 2LU, United Kingdom, 44 01392 726026.ORCID http://orcid.org/0000-0001-9147-1876
Emi Furukawa *Human Developmental Neurobiology Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa, Okinawa, Japan.ORCID http://orcid.org/0000-0002-0588-7021
Alessio BellatoSchool of Psychology, University of Southampton, Southampton, United Kingdom.ORCID http://orcid.org/0000-0001-5330-6773
Pascal-M AggensteinerCentral Institute of Mental Health, Department of Child and Adolescent Psychiatry and Psychotherapy, Mannheim, Germany.ORCID http://orcid.org/0000-0002-1048-9044
Matthew BellringerBCS, The Chartered Institute for IT, Swindon, United Kingdom.ORCID http://orcid.org/0009-0001-9037-7797
Claire CattelOxford Health NHS, Oxford, United Kingdom.ORCID http://orcid.org/0009-0005-1549-9902
Samuele CorteseSchool of Psychology, University of Southampton, Southampton, United Kingdom.ORCID http://orcid.org/0000-0001-5877-8075
David DaleyDepartment of Psychology, Nottingham Trent University, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0002-3597-0408
Manfred DöpfnerDepartment of Psychiatry and Psychotherapy of Childhood and Adolescence, Faculty of Medicine, University of Cologne, Cologne, North Rhine-Westphalia, Germany.ORCID http://orcid.org/0000-0002-4178-0424
Federica DonnoDepartment of Biomedical Sciences, Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Sardinia, Italy.ORCID http://orcid.org/0000-0002-2718-0174
Madeleine J GroomInstitute of Mental Health, University of Nottingham, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0002-5182-518X
Anna KaiserCentral Institute of Mental Health, Department of Child and Adolescent Psychiatry and Psychotherapy, Mannheim, Germany.ORCID http://orcid.org/0009-0001-6373-8278
Christina Kini-SeerySchool of Psychology, University College Dublin, Dublin, Leinster, Ireland.ORCID http://orcid.org/0000-0001-5056-8102
Katarzyna Kostyrka-AllchorneDepartment of Psychology, School of Biological and Behavioural Sciences, Queen Mary University of London, London, United Kingdom.ORCID http://orcid.org/0000-0002-0789-2449
Jonna KuntsiSocial, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.ORCID http://orcid.org/0000-0002-0113-8162
Stuart KyleLlansamlet Surgery, Swansea, United Kingdom.ORCID http://orcid.org/0000-0001-9837-6863
Elizabeth B LiddleInstitute of Mental Health, University of Nottingham, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0002-9299-094X
Giorgia MicheliniDepartment of Psychology, School of Biological and Behavioural Sciences, Queen Mary University of London, London, United Kingdom.ORCID http://orcid.org/0000-0002-0887-7582
Emilie S NordbyDivision of Psychiatry, Haukeland University Hospital, Bergen, Vestland, Norway.ORCID http://orcid.org/0000-0003-3686-8859
Nicholas PeresTorbay and South Devon NHS Foundation Trust, Torquay, England, United Kingdom.ORCID http://orcid.org/0009-0009-2642-418X
Tashinga RuziveUniversity of Exeter, Exeter, United Kingdom.ORCID http://orcid.org/0009-0009-5365-8256
Anita SalimiUniversity of Exeter, Exeter, United Kingdom.
Douglas SjöwallDepartment of Clinical Neuroscience, Karolinska Institutet, Sweden, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8320-3609
Edmund J S Sonuga-BarkeInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.ORCID http://orcid.org/0000-0002-6996-3935
James WengerUniversity of Exeter, Exeter, United Kingdom.ORCID http://orcid.org/0009-0000-9414-6286
Tamsin Newlove-DelgadoFaculty of Health and Life Sciences, University of Exeter, Room 2.05, South Cloisters, University of Exeter St Luke's Campus Heavitree Road, Exeter, EX1 2LU, United Kingdom, 44 01392 726026.ORCID http://orcid.org/0000-0002-5192-3724

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Digital technologies are becoming an important part of health care, including for individuals with attention-deficit/hyperactivity disorder (ADHD). Digital health innovations present valuable opportunities to provide flexible and tailored support for their diverse needs, along with significant challenges. Attentional, organizational, and motivational characteristics associated with ADHD may affect how individuals engage with digital tools. Potential risks include additional access barriers, the exclusion of underserved groups, and diminished quality of care. To help reduce these risks, the development, evaluation, and implementation of digital tools must be person-centered and guided by a comprehensive understanding of the diverse needs of all stakeholders. Objective: To advance research in this area, a multidisciplinary panel of ADHD specialists, technology experts, and individuals with lived experience of ADHD was formed. The panel worked together to agree on key priorities and considerations for developing, evaluating, and implementing digital technologies for ADHD. The recommendations are designed to be shared with the wider research community and to guide innovations in ADHD digital health to improve care. Methods: A modified Delphi approach was used to develop consensus. Key statements were drafted, building on discussions held during the European Network for ADHD (EUNETHYDIS) Special Interest Group meeting in 2024. An expert panel that included additional key stakeholders was convened. Draft statements were shared with panel members via a 2-round Delphi survey and discussion meetings, with final statements coproduced by the panel. Insights from multiple perspectives were incorporated, and consensus agreement was sought. Refined statements were shared with EUNETHYDIS members for ratification. Panel members were invited to contribute as coauthors. Results: An expert panel of 28 members (21 EUNETHYDIS Special Interest Group members, 7 invited experts) coproduced 30 consensus statements on ADHD and digital health. Agreement ranged from 78.6% (22/28) to 100% (28/28) for the first round (19 statements) and from 92.6% (25/27) to 100% (27/27) for the second round (30 statements). Final statements covered 4 topic areas: Opportunities and Aspirations, Development and Evaluation, Implementation, and Risks and Unintended Consequences. These were ratified in September 2025 by the EUNETHYDIS. Conclusions: This consensus process provides the first comprehensive set of key considerations for digital health care for people with ADHD and demonstrates the feasibility of achieving expert agreement on complex, rapidly evolving topics, such as digital health. Future work should focus on translating these considerations into more specific and practical implementation frameworks, identifying priorities, and connecting them to real-life stories and empirical evidence.

Indexed as

Attention Deficit Disorder with HyperactivityDelphi TechniqueDigital HealthEuropeHumansADHDattention-deficit/hyperactivity disorderconsensusDelphidigital healthEUNETHYDISEuropean Network for ADHD

Identifiers

PMID42462051
PMCPMC13374793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.